Perrigo Company plc

Equities

PRGO

IE00BGH1M568

Pharmaceuticals

Real-time Estimate Cboe BZX 03:29:14 2024-02-26 pm EST 5-day change 1st Jan Change
32.11 USD -0.12% Intraday chart for Perrigo Company plc -0.48% -0.05%
This article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Transcript : Perrigo Company plc Presents at 2023 Morgan Stanley Global Consumer and Retail Conference, Dec-06-2023 01:30 PM
Perrigo Announces Early Results of Cash Tender Offer for Notes CI
Perrigo Co Insider Bought Shares Worth $172,106, According to a Recent SEC Filing MT
Tranche Update on Perrigo Company plc's Equity Buyback Plan announced on November 8, 2018. CI
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday MT
Transcript : Perrigo Company plc, Q3 2023 Earnings Call, Nov 07, 2023
Perrigo's Q3 Adjusted Earnings, Net Sales Rise; 2023 Reported Net Sales Guidance Lowered MT
(PRGO) PERRIGO COMPANY Sees Fiscal Year 2023 EPS Range $2.50 - $2.60 MT
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q3 Revenue $1.12B MT
Earnings Flash (PRGO) PERRIGO COMPANY Reports Q3 EPS $0.64 MT
Perrigo Company plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Perrigo Company plc Updates Earnings Guidance for the Fiscal 2023 CI
Perrigo Keeps Quarterly Dividend at $0.273; Payable Dec. 19 to Shareholders on Dec. 1 MT
Sweden's Scandi Standard Hires New CFO MT
Transcript : Perrigo Company plc Presents at Piper Sandler Growth Frontiers Conference, Sep-12-2023 10:00 AM
Perrigo Company plc Announces Executive Changes CI
UK Stocks-Factors to watch on Aug 31 RE
EMEA Morning Briefing : Cautious Sentiment Seen -2- DJ
FDA Warns Three Baby-Formula Makers Over Violations in Production DJ
U.S. FDA issues warning letters to three baby formula manufacturers RE
Perrigo Company plc Appoints Julia Brown as Member of the Board of Directors, to Be Effective November 1, 2023 CI
Transcript : Perrigo Company plc Presents at Canaccord Genuity 43rd Annual Growth Conference, Aug-09-2023 10:30 AM
Tranche Update on Perrigo Company plc's Equity Buyback Plan announced on November 8, 2018. CI
Perrigo Company plc Reports Earnings Results for the Second Quarter and Six Months Ended July 01, 2023 CI
Transcript : Perrigo Company plc, Q2 2023 Earnings Call, Aug 08, 2023
Chart Perrigo Company plc
More charts
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
32.15 USD
Average target price
44.75 USD
Spread / Average Target
+39.19%
Consensus
  1. Stock
  2. Equities
  3. Stock Perrigo Company plc - Nyse
  4. News Perrigo Company plc
  5. Perrigo Co Insider Bought Shares Worth $172,106, According to a Recent SEC Filing
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW